Csaba Kari
7Patents
3h-index
17Co-inventors
54Inventor score
Filing activity: Nov 8, 1979 → Jul 2, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8895702B2 | Development of masked therapeutic antibodies to limit off-target effects; application to anti-EGFR antibodies | Chemistry; Metallurgy | 19 | Active |
| US6448389B1 | Human cytomegalovirus DNA constructs and uses therefor | Chemistry; Metallurgy | 13 | Expired |
| US10357571B2 | Development of masked therapeutic antibodies to limit off-target effects | Chemistry; Metallurgy | 13 | Active |
| US4294927A | Genetic process for the preparation of antibiotic-producer micromonospora strains | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11311622B2 | Development of masked therapeutic antibodies to limit off-target effects | Chemistry; Metallurgy | 0 | Active |
| US5183748A | Process for the preparation of oligo- and polydeoxyribonucleotides | Chemistry; Metallurgy | 0 | Expired |
| US11186642B2 | Development of masked therapeutic antibodies to limit off-target effects: application to anti-EGFR antibodies | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.